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ABSTRACT
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Depression in the Prenatal Setting
Postpartum depression (PPD) is a mental health condition affecting approximately 1020% of pregnant women in the United States (Wilkinson, Anderson, & Wheeler, 2017). PPD is
often underdiagnosed and undertreated, leading to negative neonatal and maternal outcomes.
Early detection of PPD in the prenatal setting is crucial for the promotion of maternal and
neonatal health. Barriers have been identified with low incidence of prenatal screening, including
lack of experience, education, or skill by the health care provider, standard of care policies per
facility that do not incorporate routine PPD screening in the prenatal period, and compliance by
staff administering screening tools (Legere et al., 2017; Wilkerson et al., 2016).
The aim of the practice improvement project is to increase identification of pregnant
women at risk for developing PPD early in the prenatal setting. The purpose of this practice
improvement project is to implement a PPD screening tool, the Postpartum Depression
Predictors Inventory-Revised (PDPI-R), at the second or third trimester prenatal visit to identify
pregnant women at risk for developing PPD in an OB/GYN office setting in a Southeastern city.
The screening tool consists of 10 prenatal risk factors associated with PPD, including prenatal
depression, life stress, social support, prenatal anxiety, marital satisfaction, previous history of
depression, self-esteem, socioeconomic status, marital status, and unplanned/unwanted
pregnancy (Beck, 2002). Identification of risk factors for PPD indicate only the risk of
developing PPD in the postpartum period, allowing for identification of specific interventions to
improve the patient outcomes.
The practice improvement project was implemented December 2019 and was evaluated
after a four-week implementation period. Pre-implementation data collection consisted of chart
review for pregnant women, ages 19-45, seen by one OB/GYN physician in the prenatal setting
at their second or third trimester visit during the previous four weeks of the start of the
implementation phase. Chart audits revealed the number of patients seen by the provider that
were eligible for screening, number of patients screened for PPD, number of patients identified
as high risk for developing PPD without use of the PDPR-R tool, and number of patients with a
history of mental health illness. Prisoners, adolescents, and first trimester visit patients were
excluded. Post-implementation data analysis revealed the number of patient eligible to receive
the tool, number of patients that were administered the PDPI-R screening tool, number of
patients that declined the tool, number of patients identified as high risk for developing PPD, and
the highest prevalent risk factors. The results of the study revealed a 15% increase in the number
of patients identified as high risk for developing PPD with the use of a screening tool in the
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prenatal setting. Inconsistencies in administration of the PDPR-R tool were identified and
recommendations were made.
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Implementation of a Screening Tool for Early Detection of Postpartum Depression
in the Prenatal Setting
Postpartum depression (PPD) is a mental health condition affecting women that can lead
to detrimental effects for the mother, infant, and family unit if left undiagnosed. PPD affects 1020% of women living in the United States (Wilkinson, Anderson, & Wheeler, 2017). Evans,
Phillipi, & Gee (2015) report prevalence rates of PPD symptoms were found to be higher among
African American and Hispanic race, lower socioeconomic class, adolescent mothers,
primigravids, and/or experienced a high-risk pregnancy, with rates ranging from 21% to 60%.
No standard of care for routine screening has been established in the United States, despite
recommendations from leading experts in maternal and neonatal care. The U.S. Preventative
Services Task Force supports the need for routine prenatal screening for PPD in the promotion of
maternal and infant health (U.S. Preventative Services Task Force, 2015). The Maternal and
Child Health Bureau and the U.S. Department of Health and Human Services have identified the
need to support programs and screening in efforts to reduce incidence of PPD in the promotion
of maternal and neonatal health. The American College of Obstetrics and Gynecology (2016)
recommends screenings patients at least once in the prenatal period for depression and anxiety.
Although all women are considered high risk for developing PPD in the postpartum period,
specific risk factors are associated with its occurrence, which will be discussed in this paper. The
importance of early detection and primary prevention through early screening, maternal and
neonatal negative outcomes, and barriers associated with identification of signs of PPD will be
addressed within the paper. The impact of postpartum depression on nursing will be discussed, as
well as future nursing education and research.
Background and Significance
9

PPD is considered the leading cause of major depressive disorders in women of
childbearing age, which may result in postpartum psychosis is left untreated (Woody, Ferrari,
Siskind, Whiteford, & Harris, 2017). PPD is characterized by signs and symptoms of severe
mood swings, uncontrollable crying, irritability, suicidal ideations, fear, confusion, anger,
sadness, and infant detachment (Wilkinson et al., 2017). PPD is not always associated with
previous history of mental illness, and some women may not volunteer their symptoms for fear
of stigma associated with mental illness and pregnancy (Patel et al., 2012).
Baby Blues
PPD is often difficult to diagnose in the immediate postpartum period, as the symptoms
are similar to what is historically referred to as the “baby blues.” Symptoms include crying and
tearfulness, feelings of being overwhelmed by motherhood, and uncertainty over caregiving.
Postpartum blues is not considered a form of depression and gradually subsides. This time of
adjustment revolves around pregnancy hormone withdraw, and is greatly affected by acute sleep
deprivation and fatigue.
Postpartum Depression Symptoms
PPD symptoms, however, persist beyond the first two weeks postpartum. Fluctuations in
emotions due to the stress of labor, delivery of the infant, lifestyle change, and adjustment to
caring for the neonate, often occur in the first two weeks after delivery, and is considered a
normal finding due to hormonal changes occurring in the body after delivery of the infant,
affecting 50% -80% of women postpartum (Santoro & Peabody, 2010). Obsessive thoughts
regarding the infant are also symptoms associated with PPD, but do not include infanticide.
Postpartum Psychosis
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Postpartum psychosis involves rapid onset feelings of confusion, disorganized thoughts,
hallucinations, agitation, bizarre behavior and apparent delirium, infanticide and suicide,
constituting a medical emergency and requiring immediate intervention (Marder, 2014). Patients
with a previous diagnosis of bipolar disorder at are at greater risk for experiencing postpartum
psychosis episodes (Wesseloo et al., 2016).
Identification of the Problem
Low incidence of prenatal screening for PPD can be attributed to several factors,
including knowledge deficits and skill related to the recognition of symptoms of PPD by the
clinician, perceived lack of time by the clinician, lack of screening, and the patient’s willingness
to reveal their experiences and symptoms of PPD. Kalina (2015) reported that over 50% of
women experiencing PPD are left untreated due to lack of detection through early screening.
During the prenatal period, not all women experience symptoms of prenatal depression, although
other predictors can be identified that increase the risk of PPD in the postnatal period. Symptoms
can be missed in the postnatal period simply because the mother’s focus is often on the infant, as
well as missed appointments due to adjustments in daily routines with the new infant in the
home. A practice improvement project was designed to address the problem of low incidence of
screening for PPD. The aim of the practice improvement project is to increase identification of
pregnant women at risk for developing postpartum depression early in the prenatal setting
through a primary prevention model.
Objectives were identified to aid in the evaluation of outcomes for this practice
improvement project. The first research objective identified is to increase office staff knowledge
on the significance of PPD, causes, symptoms, and the need for prevention through early
screening in the prenatal period. The second identified research outcome includes achievement
11

goal of 100% compliance in administration of the PDPI-R screening tool. The final research
objective identified is increasing the number of patients identified as high risk through early
identification via administration of the PDPI-R screening tool.

PICOT
PICOT question: In pregnant women (P), how does prenatal screening for postpartum
depression (I) compared with no prenatal screening for postpartum depression (C), affect the
identification of patients at risk for developing postpartum depression in the postpartum period
(O) within a four-week time frame (T)?
Statement of the Problem

In efforts to reduce the incidence of PPD and negative outcomes associated with
untreated postpartum depression, routine screening in the prenatal period should be initiated by
trained clinicians. Reducing vulnerability to postpartum depression can be achieved through
primary prevention methods, such as early screening. Early recognition of PPD in the prenatal
setting by the healthcare team will ensure subsequent follow-up treatment and monitoring of
PPD in the immediate postpartum period, thus delays in treatment will be avoided, resulting in
reduced incidence of poor maternal and neonatal outcomes. Kruper & Wichman (2017), suggest
early screening for psychological conditions allows for detection of relevant clinical
manifestations associated with postpartum depression and appropriate coordination of treatment
plans. Primary prevention allows for identification of those patients at risk through
implementation of a standard screening tool, increases awareness, facilitates engagement of
preventative tools and resources, and offers reliable treatment options. Early screening reduces
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the severity and duration of symptoms of PPD and allows for opportunities for open dialog, thus
reducing the stigma for patients. Screening instruments are utilized as tools for early detection.
Patients identified as high risk should be referred to a mental health professional trained in
perinatal mood disorders for clinical assessment and evaluation, diagnosis, and establishment of
treatment plans.
Risk Factors Associated with Postpartum Depression
All pregnant women are at risk for developing postpartum depression and may
development it anytime during the first postpartum year (Beck, 2001). Beck (2001), a leading
theorist and nursing researcher in postpartum depression, identified thirteen significant risk
factors associated with postpartum depression, including prenatal depression, childcare stress,
life stress, social support, prenatal anxiety, marital satisfaction, history of previous depression,
infant temperament, maternity blues, self-esteem, socioeconomic status, marital status, and
unplanned/unwanted pregnancy (Beck, 2002). Early screening for risk factors or predictors can
reduce the likelihood of development of PPD by initiation of early prevention and treatment
methods. Patients with a history of depression or history of depression in previous pregnancies
are at greater risk for developing PPD (Patel et al., 2012). Risk factors, when identified by the
clinician, can promote better maternal and neonatal outcomes through early implementation of
interventions and follow-up care.
Negative Outcomes Associated with Postpartum Depression

Maternal mental health conditions during and after pregnancy have been associated with
negative perinatal outcomes, such as low birth weight, poor cognitive and developmental delays,
poor social skills, and psychological disorders (Accortt, Cheadle, & Schetter, 2014). Pregnant
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women with depression may engage in at-risk behaviors, such as smoking and substance abuse,
placing them at greater risk for preterm birth. Prenatal depression is also associated with
pregnancy complications, such as gestational hypertension, pre-eclampsia, gestational diabetes,
and other Perinatal Mood and Anxiety Disorders (PMADs). Negative long-term neonatal
outcomes have been identified, including difficulty with social interaction, poor cognitive
development, difficulty managing stress, and abuse and neglect. Maternal-infant attachment may
be hindered, leading to life-long problems with emotional bonding and positive social
interaction. A study completed by Paris, Bolton, and Weinberg (2009), reported that women with
high suicidality experienced greater difficulty with severe mood swings, cognitive distortions,
and severe postpartum symptomology, as well as decreased perceived self-esteem, poor infant
attachment, and were less sensitive to their infant’s cues. PPD can also lead to postpartum
psychosis if left untreated, in which the patient may experience suicidal ideations or infanticide.
Prevention through early detection is crucial in the promotion of maternal and neonatal health.
Barriers to Screening for Postpartum Depression

The lack of a standard of care for routine PPD screening and the lack of mandated
screening protocols has resulted in low incidence of PPD screening and has been identified as a
barrier in PPD screening. Routine screening for PPD has not been mandated by each state across
the U.S., lowering the incidence of routine screening. Although the Patient Protection and
Affordable Care Act of 2010 requires routine screening coverage by insurance carriers, not every
state mandates routine screening. Only two states, Illinois and New Jersey, have instituted
mandates regarding routine PPD screening and insurance coverage for maternal health treatment.
The ability of the health care provider to accurately recognize signs and symptoms of

14

PPD has identified as a barrier in the screening process for PPD. Often PPD is underdiagnosed
simply because women are not asked about symptoms despite numerous prenatal and postnatal
visits to the health care provider (Clemmons, Driscoll, & Beck, 2004). Clinicians must maintain
ongoing education for professional development to refine skills necessary to meet competencies
in maternal health.
Compliance by nurses in administration of screening tools has also been identified as a
barrier in the screening process for PPD. Although health care providers and clinicians may have
an understanding of the importance of PPD screening, compliance in accurately screening each
patient remains a problem. The length of time for interaction with the patient during the patient
visit, or perceived ability to complete screening by the nurse in a timely manner during the
patient visit contribute to the lack of compliance by the health care provider or nurse, thus
lowering the incidence of screening for PPD.
Evidence of the Problem
National
Approximately 10-20% of women in the United States are diagnosed with postpartum
depression, reaching upwards to 40-60% of women living in poverty (Kralj, 2014). Under the
Patient Protection and Affordable Care Act of 2010, federal regulations require insurance
companies to offer payment for preventative screening for PPD and provide grants to offset the
cost of managing PPD care (Santoro & Peabody, 2010). As there is no standard of care for PPD
screening in the U.S., the U.S. Preventative Services Task Force supports the need for routine
screening of pregnant women. Federal programs, such as the U.S. Department of Health and
Human Services and the Maternal and Child Health Bureau, have established health care
priorities for maternal health populations across the U.S. that support screening for PPD. The
15

American College of Obstetricians and Gynecologists (2015) recommended that routine
postpartum detection screening should be completed at least once in the prenatal setting and
OB/GYN staff is responsible for initiating follow-up and treatment.
Local/State
New Jersey was the first state to require routine postpartum depression screening in
physician offices, including OB/GYN facilities, pediatrics, and primary care (Wilkinson et al.,
2017). Farr, Denk, Dahms, & Dietz (2014), concluded that in the state of New Jersey, prenatal
and inpatient screening and education was effective and resulted in more patients being screened
for postpartum depression. State mandates should be made by policymakers in efforts to increase
incidence of routine screening in the prenatal period, thus decreasing costs for management of
PPD care. In 2004, the Illinois Medicaid system began to reimbursement for clinicians for PPD
screening, resulting in an increased incidence in routine screening practices (Santoro & Peabody,
2010). In 2016, the Provisional Report from the National Division of Health Statistics indicated
that in South Carolina, 57, 334 births were recorded, and of those, 72% were reported as having
prenatal care beginning in the first trimester (National Center for Health Statistics, 2017). There
is currently no standard of care for postpartum screening in South Carolina. Given high
percentages of patients receiving prenatal care in the first trimester in SC, routine prenatal
screening could positively affect maternal and fetal outcomes within the population.
Significance for Nursing
Maternal and neonatal nurses play an important role in the identification and management
of perinatal mood disorders. In the prenatal setting, nurses establish trusting relationships with
pregnant women as they are seen by office staff frequently during pregnancy. Routine prenatal
visits offer opportunities for nurses to promote open dialog and communication with patients that
16

may be experiencing pregnancy related stressors. This is an important time for the nurse to
employ PPD prevention methods and treatment modalities that will foster better maternal and
neonatal outcomes under the direction of the overseeing provider. Early recognition through
prenatal screening for risk factors will promote healthy outcomes, which can be nurse driven.
Review of Evidence

A review of literature was conducted to reveal evidence-based practice research for early
screening and detection of risk factors associated with postpartum depression. The literature
review was first conducted using three of 24 nursing databases, including CINAHL,
ScienceDirect, and Ovid. Key words utilized were postpartum depression, postpartum
depression screening, postpartum depression theory, postpartum depression in nursing, prenatal
depression, prenatal depression screening, and postpartum depression in the United States. Key
word search for postpartum depression via CINAHL yielded 4,707 articles. Filters were applied
for years 2011-2017 and narrowed to English articles only, yielding 2,170 articles. Articles were
selected on areas of interest, such as compliance, barriers, and standard of care. Postpartum
depression in nursing via CINAHL yielded just 35 results, while key words postpartum
depression screening yielded 117 with the same filter. Key words postpartum depression theory
was searched via CINAHL without filters. The search resulted in 11 articles. These articles were
exclusively utilized for research conducted on nurse theorist, Cheryl Beck, DNSc, CNM, FAAN.
Key words prenatal depression via CINAHL search yielded 129 articles, while prenatal
depression screening yielded 4 articles. Key words postpartum depression in the United States
via CINAHL yielded 34 articles. Articles were selected based on author, theory, utilization of the
PDPI-R tool, barriers, PPD education, neonatal outcomes, and prevalence of PPD.
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ScienceDirect generated a larger number of articles with various key words in
comparison to CINAHL. Key words postpartum depression yielded 17, 928 articles. Filters were
then applied, including English. Years of publication was an added filter. 2018 yielded 84
articles; 2017 yielded 1,130; 2016 yielded 1,079, and 2015 yielded 987 articles. Postpartum
depression in nursing yielded 4,425 articles. Publication years limited to the last 5 years resulted
in 1, 574 articles. Key word screening was added as a filter, which then resulted in 271 articles.
Articles where then selected based on author, theory, maternal and neonatal outcomes, barriers to
screening, and utilization of the PDPI-R tool.
Ovid generated the least number of relevant articles when keyword postpartum
depression was searched. 120 articles were found initially. When adding the keyword screening
and a filter of articles within the last 5 years, 494 articles were generated. Of these, articles were
selected based on compliance and neonatal outcomes. Prenatal depression search revealed 435
articles within the last 5 years. Keyword postpartum depression theory revealed 116 articles
published within the last 5 years. Keyword postpartum depression in nursing yielded the most
articles within the Ovid database with 9, 495 articles within the last 5 years. Articles were then
selected based on relevance to PPD prenatal screening, author, PPD theory, barriers to screening,
neonatal outcomes, and utilization of the PDPI-R tool.

Risk Factors
Literature reveals significant research conducted on specific risk factors associated with
the development of postpartum depression. Beck (2002), conducted a meta-analysis of studies
completed during the 1990’s, which resulted in the updated revised version of the PDPI. Thirteen
risk factors identified by Beck (2002), are included in the PDPI-R screening tool. These risk
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factors are assessed during the administration of the PDPI-R and serve as predictors of an
increased probability of development of PPD in the postnatal period. Prevention of PPD can be
achieved with early detection. Santoro and Peabody (2010) report that prenatal depression is the
number one risk factor associated with the development of PPD. Childcare stress has been
identified as a predictor of PPD, which can involve difficulties the mother experiences with
managing care, as well as any health conditions the infant may have. Traumatic or stressful life
events contribute to the overall life stress the mother may be experiencing. These life-changing
events may not necessarily be perceived as all negative events by the mother, though increase her
level of stress. Another predictor of PPD is social support, which is the perceived emotional care
from family members, mate, and friends (Beck, 2002). Beck also describes prenatal anxiety as a
risk factor for PPD, which can impact the mother at any stage during her pregnancy and involves
apprehensive emotions and feelings about perceived threats to well-being. Marital satisfaction
during pregnancy is assessed concerning the patient’s perception of communication, attention,
mutual respect, and well-being (Beck, 2002). The mother’s history of previous PPD, as well as
the temperament of the infant and the mother’s ability to manage care of the infant is assessed as
a risk factor. Presence of maternity blues is considered a normal phenomenon, generally lasting
the first two weeks in the postnatal period in which the mother may experience anxiety,
tearfulness, irritability, and mood swings, though is also identified as a risk factor for PPD. The
mother’s perceived self-worth and self-esteem can directly impact the mother’s perceived ability
to manage care of the infant and confidence level. Socioeconomic status and marital status are
also risk factors associated with PPD. The level of education, financial ability or constraints,
occupation, and degree of income, as well as marital status, whether divorced, unmarried,
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widowed, or married, are assessed. The final risk factor assessed with the PDPI-R is unplanned
or unwanted pregnancy.
A longitudinal cohort study completed by Leung, Letourneau, Giesbrecht, Ntanda, &
Hart (2017), revealed that predictors of PPD in women included low socioeconomic status, low
household income, low social support, smoking, high prenatal depressive symptoms, and a high
number of stressful life events. The purpose of the study was to determine PPD predictors at
three months postpartum by comparing depressed couples with couples with one parent with
depressive symptoms. The study also revealed that fathers experienced PPD predictors similar to
those of the mothers, including low household income, low social support, smoking, and high
prenatal depressive symptoms.
A meta-analysis conducted by O’Hare & Swain (1996), reported predictors of postpartum
depression were past history of depressive symptoms, negative perceived marital relationships,
low social support, low socioeconomic status, and stressful life events. This quantitative metaanalysis was conducted to determine the effects of risk factors during pregnancy for postpartum
depression. The authors reported the results of the study mirrored previous research on risk
factor for PPD.
Negative Outcomes
Untreated and undiagnosed PPD can lead to detrimental effects on maternal and neonatal
outcomes. Chaudron, Szilagyi, Campbell, Mounts, & McInerny (2007) reported that children
exposed to maternal mental health conditions are adversely affected either by direct means or
indirect means. Direct means may include impaired attachment, abuse, and neglect. Indirect
means include missed well-child appointments, cessation of breastfeeding, and lack of
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compliance with car seat safety measures. Direct and indirect effects of PPD result in life-long
difficulties for the infant.
Untreated PPD also impacts health care costs in a variety of ways. Earl (2010) reported
that “PPD leads to increased costs of medical care, inappropriate medical care, child abuse and
neglect, discontinuation of breastfeeding, family dysfunction, and adversely affects early brain
development” (p.1033). Kruper & Wichman (2017), conclude that maternal mental health
disorders are directly linked to poor neonatal outcomes. Kruper & Wichman also report that
untreated mental disorders in pregnant women negatively affect adherence to prenatal care, thus
increase cost due to increased need for healthcare, as well as increase morbidity and mortality.
Earl (2010) also reported that PPD affects the maternal-infant relationship, creating an
environment that adversely effects the infant’s brain development, leading to impaired social
interaction and delays in development. Early maternal-infant attachment is crucial in the
development of cognitive abilities and well-being of the infant.
Spooner, Rastle, & Elmore (2012), suggest that quality prenatal social support structures,
including network resources, have a direct impact on maternal & neonatal outcomes. Early
identification of social and family support systems allows an opportunity for clinicians to
properly intervene. Prevention strategies in the prenatal period can be implemented to decrease
the development and progression of PPD in the postnatal period.
Barriers
Establishment of routine prenatal screening for PPD in the prenatal setting is necessary
for early recognition and development of prevention strategies in the patient’s plan of care. As
only one state in the U.S. has initiated mandatory routine screening as a standard of care for
maternal health, it is vital for all states to follow suit, requiring mandatory screening for PPD.
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Screening is a crucial component in detection of those patients at risk. A study completed by
O’Connor, Rossom, Henninger, Groom, & Burda (2016), supports the need for early detection of
postpartum depression through routine screening, which may reduce depressive symptoms and
prevalence of depression in the population.
In the women’s health arena, clinicians must be vigilant in demonstrating best practices
in alignment with current evidence-based practice guidelines. Recognition depends not only on
skill and education specific to PPD by the health care provider, but also awareness during contact
with the patient. PPD symptoms can be missed during postpartum visits or well-baby checkups
due missed appointments or focus on the baby (Lind, Richter, Craft, & Shapiro, 2015). PPD is a
complex condition that requires accurate assessment skills and knowledge for the recognition
and monitoring of PPD. A study completed by Legere et al. (2017) suggests that “there is a need
for initial education and ongoing professional development to improve the knowledge of
perinatal depression, identification and intervention skills of health-care professionals caring for
perinatal women at risk” (p.13).
Compliance by clinicians in the administration of PPD screening tools is also considered
a barrier in identification of patients at risk for developing PPD. Psaros, Geller, Sciscione, &
Bonacquisti (2010), completed a study regarding frequency in utilization of PPD screening tools
among physicians, nurses, and midwives. The study reported that of those who did not routinely
screen patients, 15% stated they had intended to use a screening tool, but did not due to time
constraints.
Upon completion of a synthesis of literature on the risk factors of PPD, negative maternal
and neonatal outcomes, and barriers to early PPD screening, it was determined that early
detection of PPD through routine screening in the prenatal setting would increase the incidence
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of PPD screening, thus improving patient safety and outcomes. A practice improvement project,
aimed at increasing the number of patients identified as at-risk for developing PPD in the
prenatal period, was developed. A valid and reliable screening tool was selected for
administration in the project, proven to be appropriate for the prenatal setting.
Conceptual Framework
Nursing theoretical frameworks provide the foundation for applied knowledge in
evidence-based practice and practice improvement projects. Nursing professionals utilize nursing
theory to provide a foundation to build patient a centered plan of care. To narrow the focus of the
conceptual framework for the project with a focus on PPD, Teetering on the Edge Theory of
Postpartum Depression was selected.
Teetering on the Edge Theory of Postpartum Depression
Dr. Cheryl Beck, middle-range theorist, developed Teetering on the Edge Theory of
Postpartum Depression. Her conceptual theory model has been utilized for the identification of
pregnant women at risk for developing PPD. The theory provides a foundation for application of
nursing knowledge in supporting women in varying stages of PPD. Beck describes four stages of
PPD within the structure of her theory: encountering terror, dying of self, struggling to survive,
and regaining control, all of which encompass loss of control (Marsh, 2013). During assessment
of the patient, the nurse can utilize his or her nursing judgement to appropriately make
associations with patient symptoms and the stages of PPD. Through proper recognition of the
stages of PPD by the clinician, intervention can be implemented to provide treatment options and
support. Patients with a previous history of PPD, or patients experiencing depressive symptoms
in the prenatal period, must be monitored closely. During the implementation phase of the
project, education will be provided for staff on the four stages of PPD. Focused attention of the
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importance of awareness, recognition of symptoms and behaviors congruent with PPD, and
support for the patient, will be provided.
Model of Motivational Design
During the implementation of the project, educational sessions with office clinicians, and
proper administration of the screening tool for PPD, the DNP role integrates adult learning
theory, application and nursing practice. It is important to apply an adult learning theory for
inclusion as a foundational nursing theory. The DNP nurse educator must assess the learning
styles of the learner in attempts to provide an effective learning environment. In 1987, John
Keller, and instructional theorist, developed a Model for Motivational Design, in which he
focused on four essential human behavioral aspects that must be engaged by the learner during
the learning process (Gatti-Petito et al., 2013). The four aspects include attention, which spurs
the learner’s interest; relevance, which the learner can associate previously learned knowledge;
confidence, which builds as the learner acquires new knowledge; and satisfaction, which can be
an intrinsic reaction to learning (Gatti-Petito et al., 2013). While the DNP educator is apt in
application of theoretical concepts and theory, application of Keller’s Model of Motivational
Design will enhance the learners experience and retention of knowledge and concepts in the
educational session. The DNP educator can encourage and promote learning through strategies
and teaching techniques that incorporate the student’s active participation, such as role play,
demonstration with error correction, and opportunities for feedback.
Methodology
The practice improvement project was implemented in an OB/GYN physician office
setting in South Carolina. A needs assessment was completed by the principle investigator in
collaboration with the office Clinical Coordinator and RN staff. It was confirmed that routine
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screening for PPD was not included in the care of patients within the practice. No screening tool
was used in practice by the providers nor the nursing staff. During the patient interview by the
RN during the patients second trimester visit (approximately 13 weeks gestation), it was revealed
that patients were not routinely asked about their mental health by the nursing staff. The
OB/GYN office is owned by a county hospital network, consisting of five OB/GYN physicians.
One physician has been identified as the author’s collaborative partner and mentor. The Practice
Manager and Clinical Coordinator (RN) assisted in collaboration with the project. The initial
meeting with the office staff revealed open communication and the proposed project was well
received. An overview of the project was presented, including components of the educational
session, administration of the tool, timeframe of completion, and level of commitment and
involvement of the staff.
Instruments and Education
Concluding a literature review on varying screening tools for PPD, a valid and reliable
screening tool was selected. The Postpartum Depression Predictors Inventory-Revised screening
tool is a 32-item scale with 13 subscales representing risk factors of PPD. The tool includes 10
predictors specific to prenatal factors and 3 postnatal factors. The 10 prenatal factors include
marital status, socioeconomic status, self-esteem, prenatal depression, prenatal anxiety,
unwanted/unplanned pregnancy, history of previous depression, social support from
husband/mate, family and friends, marital satisfaction, and life stresses (Youn & Jeong, 2011).
As indicated by Youn & Jeong (2011), the PDPI-R is appropriate for administration during the
prenatal setting.
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Postpartum Depression Predictor Inventory-Revised
Explicit written permission was received by the author and developer of the PDPI-R
screening tool. The tool was published in the public domain and written permission was not
deemed necessary, as described by the author, Dr. Cheryl Beck. Written permission will be
included as an appendix.

Validity and reliability.
A study completed by Youn & Jeong (2011), tested predictive reliability of the PDPI-R
via a descriptive cross-sectional design study revealing good predictive validity and “.927 for the
full version. The sensitivity and specificity were 87.3% and 85.1%, respectively, at a cutoff point
of 9.5 for the full version, and 91.5% and 66.1%, respectively, at a cutoff point of 5.5 for the
prenatal version” (p. 214). A study completed by Oppo et al. (2008) tested the validity and
reliability of the PDPI-R and concluded that “the Prenatal and Full Version of the PDPI-R
predicted accurately 80.3% and 882.2% of PPD. The prenatal PDPI-R yielded sensitivity of .72
and specificity of .74 and a cut-off score of 4.5, while the Full Version yielded .83. The PDPI-R
is a useful and valid screener for PPD” (S259). The literature also reveals another study
completed by Oppo et al. (2009), concluding “The prenatal version of the PDPI-R administered
at two different time points during pregnancy predicted accurately 72.6% and 78.2% of PPD and
the full version administered at the 1st month after delivery predicted 83.4% of PPD. The cutoffs
identified were 3.5 for the prenatal version and 5.5 for the full version. The PDPI-R is a useful
and a valid screening tool for PPD” (p.239).
Based on validity and the structure of the PDPI-R, the tool was selected as an appropriate
tool to be utilized in the project for the prenatal period. The tool was deemed useful in the
prenatal setting and should be administered by a trained clinician, in which the tool also provides
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guide questions for the clinician for optimal clarity for the patient during administration. The tool
should be administered in an appropriate setting by the clinician which fosters open
communication and safety for sharing of emotions and experiences.
Postpartum Depression Staff Education
Educational training was conducted to include the physician, registered nurses
responsible for administering the tool, and the medical assistant to establish a united front in the
significance of postpartum depression, as well as a culture of caring for pregnant women at risk
for developing postpartum depression. A lunch-and-learn was provided by the principle
investigator during the educational session. The educational session concluded after 30 minutes.
Participants were asked to attend the educational session and complete an evaluation to validate
learning and perception of the educational session experience. The educational session was
provided in two sessions to reinforce accurate understanding of the implementation process and
to identify areas of uncertainty for staff. Resources utilized included PowerPoint for visual
learners, the PDPI-R document, role play with demonstration, and additional time for open
dialog was provided to encourage and promote motivational learning. Staff was receptive to
learning and actively participated in the educational session.
Staff Education for Administration of Tool
The office registered nurse was responsible for administering the tool. During the second
or third trimester prenatal visit, the registered will administer the PDPI-R screening tool with the
subject for identification of risk factors associated with PPD. Specific training was provided
during the training session, including proper administration of the PDPI-R tool and guide
questions for the 10 prenatal predictors that clinicians can utilize to promote open dialog with the
patient. Training on administration of the tool was included in the educational session.
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Administration of the tool was completed in the patient room, and privacy was provided to foster
a safe, calm environment for open communication and accurate documentation. If the subject
scores a minimum of 10.5 on the screening tool, an indication can be asserted that the subject is
at high risk for developing postpartum depression (Beck, 2002). During the educational session
for the administration of the tool, the registered nurse was trained on properly flagging the chart
via EPIC, the electronic health record (EHR) in use within the organization. This provided a
means to alert the physician of the high-risk score. The nurse was also instructed on proper
documentation of the administration of the tool and high or low risk score. The nurse was also
instructed on interpreting the patient score via instructions provided by Dr. Cheryl Beck’s PDPIR tool. The PDPI-R tool and patient consent form was provided in paper and pen format by the
principle investigator. The nurse was trained to provide a copy of the patient consent form to the
patient upon agreement to accept the screening tool. The tool was administered and scored by the
nurse. The score was documented in the EHR as an encounter note by the nurse. All high-risk
scores were documented as an encounter note. To alert the physician of a high-risk score, the
nurse documented a task note, which prompted the physician to respond with orders. The
physician then ordered follow up treatment to return for additional office visit with the physician
or ordered a referral to counseling with a licensed professional. The registered nurse was trained
to respond to all physician responses with accuracy to ensure follow-up treatment was
implemented.
Institutional Review Board Approval
The Institutional Review Board (IRB) at the University of Alabama Huntsville (UAH) is
committed to protected the rights and privacy of all human subjects participating in research
projects in relation to enrolled student involvement. In compliance with Federal Government
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regulations and guidelines exhibited in the Title 45 of the Code of Federal Regulations, Part 46,
the UAH requires all research projects involving human subjects be subject to approval from the
IRB department. IRB approval provides an assurance that research projects produced are in strict
compliance with the regulations and policies of the Federal Government, thus providing safety
and confidentiality to human subjects, minimal risk has been as established in relation to the
benefit of the project, subjects are adequately informed and consent is voluntary, and the project
excludes vulnerable populations. IRB approval was obtained on November 28, 2018. See
Appendix XXXX. See Appendix XXX for informed consent document.
Implementation
The aim of this practice improvement project is to implement the Postpartum Depression
Predictor Inventory-Revised (PDPI-R) screening tool for identification of patients at risk for
developing PPD early in second or third trimester of pregnancy. The tool was administered by
the registered nurse to each pregnant patient during the second or third trimester prenatal visit for
a four-week period. The instrument was provided to the office staff by the Principal Investigator
in paper and pencil format. The tool was administered in the privacy of the patient room with
only the patient and the registered nurse present. All family members were escorted to the family
waiting area upon agreement with the patient. The patient was informed the tool will be
administered and consent documentation was obtained by the registered nurse. The patient was
given a copy of the signed consent form. Documentation of administration of the tool was
documented by the nurse regardless of risk score. All high-risk scores were reported to the
physician via the EHR through a task note. The physician responded with orders. The physician
was then notified of the score, including high-risk scores and the patient was seen by the
physician on the same day. No patients presented with suicidal ideations. A plan was in place to
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address this issue. Patients who present with suicidal or homicidal thoughts were referred to the
hospital for urgent psychiatric treatment by the physician. Those patients flagged as high risk
were referred for a consult with a licensed professional for mental health counseling. Immediate
follow-up for intervention was initiated by the registered nurse upon in compliance with the
physician order.
Data Collection
In accordance with the Health Insurance Portability and Accountability Act (HIPPA)
regulations and policies in place at Lexington Women’s Care Sandhills, the principle investigator
of the project was in full awareness of HIPPA regulations and acted in strict compliance with
patient confidentiality during chart audits and only information obtained was for the completion
of the Data Collection tool. Data was collected via chart review four weeks prior to
implementation of the screening tool. Charts were reviewed via the Electronic Medical Record
(EMR). A Data Collection tool was developed by the principle investigator of the project. See
Appendix D for the Data Collection document. Search criteria included pregnant females in the
second or third trimester of pregnancy, ages 19-49, and not of a vulnerable population.
Vulnerable patient populations were excluded from the chart review, including patients under the
age of 19 and incarcerated patients. Patient identifiers were excluded from the Data Collection
document. A further search filter was added to obtain previous history of a mental health
disorder. Chart reviews included the number of patients identified as high-risk without
administration of a screening tool in the prenatal period. At the conclusion of the implementation
period, data was collected via chart review to include the number of patients seen by the provider
during the second or third trimester visit, the number of patients that was administered the PDPIR tool, number of patients that were identified as high risk for developing postpartum depression,
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and the number of patients with a previous history of mental health disease. The postimplementation chart review included the same filters as the pre-implementation chart review.
The Data Collection tool was also utilized for chart review documentation during the postimplementation phase. For patients who scored high-risk on the PDPI-R tool, information was
obtained from the chart review regarding appropriate steps taken by the nursing staff, including
reporting of the PDPI-R score to the physician the day of the administration of the tool, proper
documentation of the score in the chart, and information regarding intervention, such as referral
to social worker for mental health counseling.
Evaluation
The evaluation process of the project included a comparison analysis. The variables
included the number of patients in the second or third trimester seen by the physician, ages 1949, number of patients that were administered the PDPI-R tool, and the number of patients
identified as high-risk for developing PPD based on a high- risk score. Comparison was made on
the two different groups, including those who met the criteria in the pre-implementation period
and those seen in the post-implementation period. The data was then evaluated to establish a
percentage representing the number of patients at risk for developing PPD. Project objectives
were identified early in this paper. The research objective number one involved increasing office
staff knowledge on the significance of PPD, causes, symptoms, and the need for prevention
through early screening. This outcome was evaluated based on the number of staff members that
completed the educational session training and evaluation form. The research objective number
two involved achievement goal of 100% compliance in administration of the PDPI-R screening
tool. This outcome was evaluated based on the total number of patients seen by the physician in
the second or third trimester, ages 19-49, and the total number of patients seen by the physician
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in the second or third trimester in which administration of the PDPI-R tool was validated. The
research objective number three involved the increased number of patients identified as high risk
through early identification via administration of the PDPI-R screening tool. At completion of
the project, pre-implementation data collection on the number of patients identified as high risk
for developing PPD was compared to the post-implementation data collection on the number of
patients identified as high-risk for developing PPD.

Objective number one.
1. Increase office staff knowledge on the significance of PPD, causes, symptoms, and
the need for prevention through early screening in the prenatal period.
The evaluation method used for objective number one involved analysis of the number
office clinicians that completed the educational session training and the number of office
clinicians that completed the Post Test with 100% accuracy, validating competency in proper
administration of the PDPI-R tool. The educational sessions were provided by the principle
investigator in two thirty-minute lunch & learn sessions. For clinicians who did not score 100%
on the Post Test, additional training was required. Four clinicians completed training session
number one. Four clinicians completed training session number two. For educational training
session number one, four clinicians completed the Post Test with 100% accuracy, validating
competency in proper administration of the PDPI-R tool. For educational training session
number two, four clinicians completed the Post Test with 100% accuracy, validating competency
in proper administration of the PDPI-R tool.

Objective number two.
2. Achievement goal of 100% compliance in administration of the PDPI-R screening
tool.
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Evaluation of research objective number two was determined in the post-implementation
phase of the project after administration of the PDPI-R tool was enforced for 100% compliance
by the office clinicians. The evaluation method involved analysis of the total number of eligible
patients seen, that met the criteria and the total number of patients seen in which administration
of the PDPI-R tool could be validated via the chart review.

Objective number three.
3. Increasing the number of patients identified as high risk through early
identification via administration of the PDPI-R screening tool.
Research objective number three involved an increase in the number of patients identified
as high-risk for developing PPD. Evaluation was determined in the post-implementation data
collection through comparison analysis of the total number of patients seen in the preimplementation phase of the project who met the criteria and the total number of patients seen in
the post-implementation phase of the project who met the criteria and was administered the
PDPI-R tool. The numbers were compared to reveal if the implementation of the PDPI-R
increased the number of patients identified as high risk in the second trimester of pregnancy.
Results: Presentation of Findings
After completion of the practice improvement project, a comparison analysis was
performed to reveal the outcomes of the research objectives defined within the project as met or
not met. Each research objective was systematically approached and results are as follow.

Objective number one.
1. Increase office staff knowledge on the significance of PPD, causes, symptoms, and
the need for prevention through early screening in the prenatal period.

33

Of the number of office clinicians identified as participants in the project improvement
project, all participants completed the Educational Training Sessions. 100% completed the Post
Test with 100% mastery to validate competency. All participants completed the Educational
Session Evaluation form to provide feedback on the Principle Investigator’s training
performance and perception of the Educational Session experience. Research objective number
one was met at 100%.

Objective number two.
2. Achievement goal of 100% compliance in administration of the PDPI-R screening
tool.
After the post-implementation chart review, data collection revealed that during the
implementation period, 63 eligible patients were identified that met the criteria. Of those, 41
patients had been administered the PDPI-R tool. Of the 63 eligible patients, three had not been
administered the tool. 18 patients declined to participate. Research objective number two was
partially met: 4.8 % (3 pts) were not offered the tool due to perceived time constraints, 28.6%
(18 pts) declined, 65.1% (41) accepted the tool.

Objective number three.
3. Increasing the number of patients identified as high risk through early identification
via administration of the PDPI-R screening tool.
The final research objective was evaluated during the post-implementation phase of the
practice improvement project. Analysis of the data collection revealed that 119 eligible patients
was seen during the pre-implementation phase. Of those, zero patients were identified as highrisk for developing PPD. Data revealed that 19 of those patients had a previous history of a
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mental health disorder. Two of those 19 received follow-up care. 117 patients of the eligible
patients did not receive any PPD screening or follow-up treatment.
Analysis of the data collection revealed that 63 patients were seen that met the criteria for
inclusion during the post-implementation phase. Of those, six patients were identified as highrisk with administration of the PDPI-R tool. In comparison, data collection revealed that 15% of
patients were identified as high-risk with administration of the PDPI-R tool. Research objective
three was met.
Limitations
A limitation identified with the construct of the practice improvement project was the
length of the implementation period. The methodology of the design included a four-week preimplementation and implementation period in which data collection through chart review was
conducted. Thus, the sample size was limited to the number of patients within the short window
of four-weeks. The implementation period was also conducted during a holiday season which
impacted the number of patients seen in the office and the number of days the physician had to
accommodate patients in the office.
A second limitation identified with the practice improvement project was compliance of
the nursing staff to administer the tool to each patient seen at the second trimester. Education on
the importance of 100% compliance during the implementation period was integrated into the
staff educational sessions, although it was discovered during the chart review of the
implementation period that three patients were not administered the tool due to perceived lack of
time to administer the tool by the nursing staff.
Recommendations
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The initial data analysis results of the practice improvement project proved that the
project implementation was successful in increasing the number of patients identified as at risk
for developing PPD. The primary prevention model for early detection was properly executed
and objective numbers one and three were met successfully. Objective number two was partially
met. In efforts to decrease the number of women diagnosed with PPD in the postnatal period, it
is recommended that prenatal screening be implemented in the OB/GYN office setting. Routine
screening will increase the number of patients identified as high risk, thus follow-up treatment
and care can be provided.
Recommendations on future projects with similar design include improving analytical
data results by increasing the length of the implementation period. A longer implementation
period will yield a larger sample size, thus improving validity of the project results. In efforts to
increase the sample size of the project, it is also recommended that the sample size could be
increased with utilization of more than one physician patient group.
A second recommendation for future projects is to incorporate more education for staff
on the importance of 100% compliance in administration of the tool during the implementation
period. Visual demonstration of the steps involved in proper placement of the PDPI-R document
within the designated nursing department may increase the compliance rate of staff as well.
A final recommendation would be for integration of the PDPI-R within the Electronic
Health Record (EHR) for improvement in staff compliance. A hard stop could be incorporated
into the EHR that would ultimately force staff to administer the tool for specific patients based
on the reason for their visit. This hard stop would be integrated into the EHR by the Information
Technology department within the facility and staff education would be provided. This
recommendation is made to increase staff compliance and ease of use for the clinician.
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Professional Journal Selection

Birth: Issues in Perinatal Care was selected as the professional journal for manuscript
submission post completion of the project based on content of previous accepted manuscripts for
publication and target audience of the journal.
Scope of the Journal
This journal is written for and by maternal and neonatal health care professionals
practicing and caring for childbearing women, infants, and families. Birth: Issues in Perinatal
Care issues peer-reviewed articles with focus on women’s health, and is appropriate for Labor
and Delivery nurses, neonatal nurses, midwives, physicians, public health workers, doulas,
lactation consultants, childbirth educators, and other caregivers and policymakers in perinatal
care (International Academy of Nursing Editors, 2017).
Aim of the Journal
According to the International Academy of Nursing Editors (2017), Birth has identified
the aim of the journal, which includes publishing original, well-designed, peer-reviewed research
on issues in pregnancy and childbirth. The journal indicates the importance of evidence-based
research in changing clinical practices and seeks to present a forum for discussing current issues
in maternal and newborn care. Birth is dedicated to providing articles on topics of major
importance in perinatal care and analysis of birth experiences of low-risk women.
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Abstract

Background: Postpartum depression (PPD) is a mental health condition affecting approximately
10-20% of pregnant women in the United States (Wilkinson, Anderson, & Wheeler, 2017). PPD
is often underdiagnosed and undertreated, leading to negative neonatal and maternal outcomes.
The aim of this practice improvement project is to implement the Postpartum Depression
Predictor Inventory-Revised (PDPI-R) screening tool for identification of patients at risk for
developing PPD early in second or third trimester of pregnancy.
Objective number one: increase office staff knowledge on the significance of PPD, causes, and
symptoms. Objective number two: 100% compliance in administration of the PDPI-R screening
tool. Objective number: increase the number of patients identified as high risk with use of
screening tool.
Methods: The project was implemented over a four-week period in an OB/GYN office in a
southeastern state. Pre-implementation chart review was completed to reveal the number of
patients identified as high-risk for PPD in the prenatal setting without use of a screening tool.
Post-implementation chart review completed to reveal number of patients identified as high-risk
with use of the Postpartum Depression Predictor Inventory-Revised screening tool.
Results: Pre-implementation data analysis concluded 119 patients met criteria for screening. Of
those, 117 did not receive screening. Nineteen patients had a history of mental health disorder,
received follow-up care. Post-implementation data revealed 61 patients eligible, 41 screened, 18
declined screening, 3 were not offered screening, and six screened high-risk.
Conclusion: 15% increase in the number of patients identified as high-risk with the use of the
screening tool.
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Postpartum depression (PPD) is a mental health condition affecting women that can lead
to detrimental effects for the mother, infant, and family unit if left undiagnosed. PPD affects 1020% of women living in the United States (Wilkinson, Anderson, & Wheeler, 2017). Evans,
Phillipi, & Gee (2015) report prevalence rates of PPD symptoms were found to be higher among
African American and Hispanic race, lower socioeconomic class, adolescent mothers,
primigravids, and/or experienced a high-risk pregnancy, with rates ranging from 21% to 60%.
No standard of care for routine screening has been established in the United States, despite
recommendations from leading experts in maternal and neonatal care. The U.S. Preventative
Services Task Force supports the need for routine prenatal screening for PPD in the promotion of
maternal and infant health (U.S. Preventative Services Task Force, 2015). The Maternal and
Child Health Bureau and the U.S. Department of Health and Human Services have identified the
need to support programs and screening in efforts to reduce incidence of PPD in the promotion
of maternal and neonatal health. The American College of Obstetrics and Gynecology (2016)
recommends screenings patients at least once in the prenatal period for depression and anxiety.
Although all women are considered high risk for developing PPD in the postpartum period,
specific risk factors are associated with its occurrence, which will be discussed in this paper. The
importance of early detection and primary prevention through early screening, maternal and
neonatal negative outcomes, and barriers associated with identification of signs of PPD will be
addressed within the paper.
Background and Significance
PPD is considered the leading cause of major depressive disorders in women of
childbearing age, which may result in postpartum psychosis is left untreated (Woody, Ferrari,
Siskind, Whiteford, & Harris, 2017). PPD is characterized by signs and symptoms of severe
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mood swings, uncontrollable crying, irritability, suicidal ideations, fear, confusion, anger,
sadness, and infant detachment (Wilkinson et al., 2017).
Baby Blues
PPD is often difficult to diagnose in the immediate postpartum period, as the symptoms
are similar to what is historically referred to as the “baby blues.” Symptoms include crying and
tearfulness, feelings of being overwhelmed by motherhood, and uncertainty over caregiving.
Postpartum blues is not considered a form of depression and gradually subsides.
Postpartum Depression Symptoms

PPD symptoms, however, persist beyond the first two weeks postpartum. Fluctuations in
emotions due to the stress of labor, delivery of the infant, lifestyle change, and adjustment to
caring for the neonate, often occur in the first two weeks after delivery, and is considered a
normal finding due to hormonal changes occurring in the body after delivery of the infant,
affecting 50% -80% of women postpartum (Santoro & Peabody, 2010). Obsessive thoughts
regarding the infant are also symptoms associated with PPD, but do not include infanticide.
Postpartum Psychosis
Postpartum psychosis involves rapid onset feelings of confusion, disorganized thoughts,
hallucinations, agitation, bizarre behavior and apparent delirium, infanticide and suicide,
constituting a medical emergency and requiring immediate intervention (Marder, 2014). Patients
with a previous diagnosis of bipolar disorder at are at greater risk for experiencing postpartum
psychosis episodes (Wesseloo et al., 2016).
Identification of the Problem
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Low incidence of prenatal screening for PPD can be attributed to several factors,
including knowledge deficits and skill related to the recognition of symptoms of PPD by the
clinician, perceived lack of time by the clinician, lack of screening, and the patient’s willingness
to reveal their experiences and symptoms of PPD. Kalina (2015) reported that over 50% of
women experiencing PPD are left untreated due to lack of detection through early screening.
During the prenatal period, not all women experience symptoms of prenatal depression, although
other predictors can be identified that increase the risk of PPD in the postnatal period. Symptoms
can be missed in the postnatal period simply because the mother’s focus is often on the infant, as
well as missed appointments due to adjustments in daily routines with the new infant in the
home. A practice improvement project was designed to address the problem of low incidence of
screening for PPD. The aim of the practice improvement project is to increase identification of
pregnant women at risk for developing postpartum depression early in the prenatal setting
through a primary prevention model.
Objectives were identified to aid in the evaluation of outcomes for this practice
improvement project. The first research objective identified is to increase office staff knowledge
on the significance of PPD, causes, symptoms, and the need for prevention through early
screening in the prenatal period. The second identified research outcome includes achievement
goal of 100% compliance in administration of the PDPI-R screening tool. The final research
objective identified is increasing the number of patients identified as high risk through early
identification via administration of the PDPI-R screening tool.
Significance for Nursing
Maternal and neonatal nurses play an important role in the identification and management
of perinatal mood disorders. In the prenatal setting, nurses establish trusting relationships with
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pregnant women as they are seen by office staff frequently during pregnancy. Routine prenatal
visits offer opportunities for nurses to promote open dialog and communication with patients that
may be experiencing pregnancy related stressors. This is an important time for the nurse to
employ PPD prevention methods and treatment modalities that will foster better maternal and
neonatal outcomes under the direction of the overseeing provider. Early recognition through
prenatal screening for risk factors will promote healthy outcomes, which can be nurse driven.
Statement of the Problem

In efforts to reduce the incidence of PPD and negative outcomes associated with
untreated postpartum depression, routine screening in the prenatal period should be initiated by
trained clinicians. Reducing vulnerability to postpartum depression can be achieved through
primary prevention methods, such as early screening. Early recognition of PPD in the prenatal
setting by the healthcare team will ensure subsequent follow-up treatment and monitoring of
PPD in the immediate postpartum period, thus delays in treatment will be avoided, resulting in
reduced incidence of poor maternal and neonatal outcomes. Kruper & Wichman (2017), suggest
early screening for psychological conditions allows for detection of relevant clinical
manifestations associated with postpartum depression and appropriate coordination of treatment
plans. Primary prevention allows for identification of those patients at risk through
implementation of a standard screening tool, increases awareness, facilitates engagement of
preventative tools and resources, and offers reliable treatment options. Early screening reduces
the severity and duration of symptoms of PPD and allows for opportunities for open dialog, thus
reducing the stigma for patients. Screening instruments are utilized as tools for early detection.
Patients identified as high risk should be referred to a mental health professional trained in
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perinatal mood disorders for clinical assessment and evaluation, diagnosis, and establishment of
treatment plans.
Evidence of the Problem
National
Approximately 10-20% of women in the United States are diagnosed with postpartum
depression, reaching upwards to 40-60% of women living in poverty (Kralj, 2014). Under the
Patient Protection and Affordable Care Act of 2010, federal regulations require insurance
companies to offer payment for preventative screening for PPD and provide grants to offset the
cost of managing PPD care (Santoro & Peabody, 2010). As there is no standard of care for PPD
screening in the U.S., the U.S. Preventative Services Task Force supports the need for routine
screening of pregnant women. Federal programs, such as the U.S. Department of Health and
Human Services and the Maternal and Child Health Bureau, have established health care
priorities for maternal health populations across the U.S. that support screening for PPD. The
American College of Obstetricians and Gynecologists (2015) recommended that routine
postpartum detection screening should be completed at least once in the prenatal setting and
OB/GYN staff is responsible for initiating follow-up and treatment.
Local/State
New Jersey was the first state to require routine postpartum depression screening in
physician offices, including OB/GYN facilities, pediatrics, and primary care (Wilkinson et al.,
2017). Farr, Denk, Dahms, & Dietz (2014), concluded that in the state of New Jersey, prenatal
and inpatient screening and education was effective and resulted in more patients being screened
for postpartum depression. State mandates should be made by policymakers in efforts to increase
incidence of routine screening in the prenatal period, thus decreasing costs for management of
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PPD care. In 2004, the Illinois Medicaid system began to reimbursement for clinicians for PPD
screening, resulting in an increased incidence in routine screening practices (Santoro & Peabody,
2010). In 2016, the Provisional Report from the National Division of Health Statistics indicated
that in South Carolina, 57, 334 births were recorded, and of those, 72% were reported as having
prenatal care beginning in the first trimester (National Center for Health Statistics, 2017). There
is currently no standard of care for postpartum screening in South Carolina.
Conceptual Framework
Nursing theoretical frameworks provide the foundation for applied knowledge in
evidence-based practice and practice improvement projects. Nursing professionals utilize nursing
theory to provide a foundation to build patient a centered plan of care. To narrow the focus of the
conceptual framework for the project with a focus on PPD, Teetering on the Edge Theory of
Postpartum Depression was selected.
Teetering on the Edge Theory of Postpartum Depression
Dr. Cheryl Beck, middle-range theorist, developed Teetering on the Edge Theory of
Postpartum Depression. Her conceptual theory model has been utilized for the identification of
pregnant women at risk for developing PPD. The theory provides a foundation for application of
nursing knowledge in supporting women in varying stages of PPD. Beck describes four stages of
PPD within the structure of her theory: encountering terror, dying of self, struggling to survive,
and regaining control, all of which encompass loss of control (Marsh, 2013).
Methodology
The practice improvement project was implemented in an OB/GYN physician office
setting in South Carolina. A needs assessment was completed by the principle investigator in
collaboration with the office Clinical Coordinator and RN staff. It was confirmed that routine
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screening for PPD was not included in the care of patients within the practice. No screening tool
was used in practice by the providers nor the nursing staff.
Instrument
The Postpartum Depression Predictors Inventory-Revised (PDPI-R) screening tool is a
32-item scale with 13 subscales representing risk factors of PPD, which was selected for the
project. The tool includes 10 predictors specific to prenatal factors and 3 postnatal factors. The
10 prenatal factors include marital status, socioeconomic status, self-esteem, prenatal depression,
prenatal anxiety, unwanted/unplanned pregnancy, history of previous depression, social support
from husband/mate, family and friends, marital satisfaction, and life stresses (Youn & Jeong,
2011).
Postpartum Depression Staff Education
Educational training was conducted to include the physician, registered nurses
responsible for administering the tool, and the medical assistant to establish a united front in the
significance of postpartum depression, as well as a culture of caring for pregnant women at risk
for developing postpartum depression. A lunch-and-learn was provided by the principle
investigator during the educational session. The educational session concluded after 30 minutes.
Participants were asked to attend the educational session and complete an evaluation to validate
learning and perception of the educational session experience. The educational session was
provided in two sessions to reinforce accurate understanding of the implementation process and
to identify areas of uncertainty for staff. Resources utilized included PowerPoint for visual
learners, the PDPI-R document, role play with demonstration, and additional time for open
dialog was provided to encourage and promote motivational learning. Staff was receptive to
learning and actively participated in the educational session.
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Staff Education for Administration of Tool
The office registered nurse was responsible for administering the tool. During the second
or third trimester prenatal visit, the registered will administer the PDPI-R screening tool with the
subject for identification of risk factors associated with PPD. Specific training was provided
during the training session, including proper administration of the PDPI-R tool and guide
questions for the 10 prenatal predictors that clinicians can utilize to promote open dialog with the
patient. Training on administration of the tool was included in the educational session.
Administration of the tool was completed in the patient room, and privacy was provided to foster
a safe, calm environment for open communication and accurate documentation. If the subject
scores a minimum of 10.5 on the screening tool, an indication can be asserted that the subject is
at high risk for developing postpartum depression (Beck, 2002). During the educational session
for the administration of the tool, the registered nurse was trained on properly flagging the chart
via EPIC, the electronic health record (EHR) in use within the organization. This provided a
means to alert the physician of the high-risk score. The nurse was also instructed on proper
documentation of the administration of the tool and high or low risk score. The nurse was also
instructed on interpreting the patient score via instructions provided by Dr. Cheryl Beck’s PDPIR tool. The PDPI-R tool and patient consent form was provided in paper and pen format by the
principle investigator. The nurse was trained to provide a copy of the patient consent form to the
patient upon agreement to accept the screening tool. The tool was administered and scored by the
nurse. The score was documented in the EHR as an encounter note by the nurse. All high-risk
scores were documented as an encounter note. To alert the physician of a high-risk score, the
nurse documented a task note, which prompted the physician to respond with orders. The
physician then ordered follow up treatment to return for additional office visit with the physician
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or ordered a referral to counseling with a licensed professional. The registered nurse was trained
to respond to all physician responses with accuracy to ensure follow-up treatment was
implemented.
Data Collection
In accordance with the Health Insurance Portability and Accountability Act (HIPPA)
regulations and policies within the host organization, the principle investigator of the project was
in full awareness of HIPPA regulations and acted in strict compliance with patient confidentiality
during chart audits and only information obtained was for the completion of the Data Collection
tool. Data was collected via chart review four weeks prior to implementation of the screening
tool. Charts were reviewed via the Electronic Medical Record (EMR). A Data Collection tool
was developed by the principle investigator of the project. See Appendix D for the Data
Collection document. Search criteria included pregnant females in the second or third trimester
of pregnancy, ages 19-49, and not of a vulnerable population. Vulnerable patient populations
were excluded from the chart review, including patients under the age of 19 and incarcerated
patients. Patient identifiers were excluded from the Data Collection document. A further search
filter was added to obtain previous history of a mental health disorder. Chart reviews included
the number of patients identified as high-risk without administration of a screening tool in the
prenatal period. At the conclusion of the implementation period, data was collected via chart
review to include the number of patients seen by the provider during the second or third trimester
visit, the number of patients that was administered the PDPI-R tool, number of patients that were
identified as high risk for developing postpartum depression, and the number of patients with a
previous history of mental health disease. The post-implementation chart review included the
same filters as the pre-implementation chart review. The Data Collection tool was also utilized
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for chart review documentation during the post-implementation phase. For patients who scored
high-risk on the PDPI-R tool, information was obtained from the chart review regarding
appropriate steps taken by the nursing staff, including reporting of the PDPI-R score to the
physician the day of the administration of the tool, proper documentation of the score in the
chart, and information regarding intervention, such as referral to social worker for mental health
counseling.
Results: Presentation of Findings
After completion of the practice improvement project, a comparison analysis was
performed to reveal the outcomes of the research objectives defined within the project as met or
not met. Each research objective was systematically approached and results are as follow.

Objective number one.
Of the number of office clinicians identified as participants in the project improvement
project, all participants completed the Educational Training Sessions. 100% completed the Post
Test with 100% mastery to validate competency. All participants completed the Educational
Session Evaluation form to provide feedback on the Principle Investigator’s training
performance and perception of the Educational Session experience. Research objective number
one was met at 100%.

Objective number two.
After the post-implementation chart review, data collection revealed that during the
implementation period, 63 eligible patients were identified that met the criteria. Of those, 41
patients had been administered the PDPI-R tool. Of the 63 eligible patients, three had not been
administered the tool. 18 patients declined to participate. Research objective number two was
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partially met: 4.8 % (3 pts) were not offered the tool due to perceived time constraints, 28.6%
(18 pts) declined, 65.1% (41) accepted the tool.

Objective number three.
The final research objective was evaluated during the post-implementation phase of the
practice improvement project. Analysis of the data collection revealed that 119 eligible patients
was seen during the pre-implementation phase. Of those, zero patients were identified as highrisk for developing PPD. Data revealed that 19 of those patients had a previous history of a
mental health disorder. Two of those 19 received follow-up care. 117 patients of the eligible
patients did not receive any PPD screening or follow-up treatment.
Analysis of the data collection revealed that 63 patients were seen that met the criteria for
inclusion during the post-implementation phase. Of those, six patients were identified as highrisk with administration of the PDPI-R tool. In comparison, data collection revealed that 15% of
patients were identified as high-risk with administration of the PDPI-R tool. Research objective
three was met.
Limitations
A limitation identified with the construct of the practice improvement project was the
length of the implementation period. The methodology of the design included a four-week preimplementation and implementation period in which data collection through chart review was
conducted. Thus, the sample size was limited to the number of patients within the short window
of four-weeks. The implementation period was also conducted during a holiday season which
impacted the number of patients seen in the office and the number of days the physician had to
accommodate patients in the office.
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A second limitation identified with the practice improvement project was compliance of
the nursing staff to administer the tool to each patient seen at the second trimester. Education on
the importance of 100% compliance during the implementation period was integrated into the
staff educational sessions, although it was discovered during the chart review of the
implementation period that three patients were not administered the tool due to perceived lack of
time to administer the tool by the nursing staff.
Conclusions and Recommendations
The initial data analysis results of the practice improvement project proved that the
project implementation was successful in increasing the number of patients identified as at risk
for developing PPD. The primary prevention model for early detection was properly executed
and objective numbers one and three were met successfully. Objective number two was partially
met. In efforts to decrease the number of women diagnosed with PPD in the postnatal period, it
is recommended that prenatal screening be implemented in the OB/GYN office setting. Routine
screening will increase the number of patients identified as high risk, thus follow-up treatment
and care can be provided.
Recommendations on future projects with similar design include improving analytical
data results by increasing the length of the implementation period. A longer implementation
period will yield a larger sample size, thus improving validity of the project results. In efforts to
increase the sample size of the project, it is also recommended that the sample size could be
increased with utilization of more than one physician patient group.
A second recommendation for future projects is to incorporate more education for staff
on the importance of 100% compliance in administration of the tool during the implementation
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period. Visual demonstration of the steps involved in proper placement of the PDPI-R document
within the designated nursing department may increase the compliance rate of staff as well.
A final recommendation would be for integration of the PDPI-R within the Electronic
Health Record (EHR) for improvement in staff compliance. A hard stop could be incorporated
into the EHR that would ultimately force staff to administer the tool for specific patients based
on the reason for their visit. This hard stop would be integrated into the EHR by the Information
Technology department within the facility and staff education would be provided. This
recommendation is made to increase staff compliance and ease of use for the clinician.
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Tables
Table 1. Postpartum Depression Predictor Inventory-Revised (2002).
TABLE 1

Postpartum Depression Predictors Inventory (PDPI)-Revised and Guide Questions for Its Use
During Pregnancy
Marital Status
1. Single
2. Married/cohabitating
3. Separated
4. Divorced
5. Widowed
6. Partnered

Check One
0
0
0
0
0
0

Socioeconomic status
Low
Middle
High

0
0
0

Self-esteem
Do you feel good about yourself as a person?
Do you feel worthwhile?
Do you feel you have a number of good qualities as a person?
Prenatal depression
1. Have you felt depressed during your pregnancy?
If yes, when and how long have you been feeling this way?
If yes, how mild or severe would you consider your depression?
Prenatal anxiety
Have you been feeling anxious during your pregnancy?
If yes, how long have you been feeling this way?
Unplanned/unwanted pregnancy
Was the pregnancy planned?
Is the pregnancy unwanted?
History of previous depression
1. Before this pregnancy, have you ever been depressed?
If yes, when did you experience this depression?
If yes, have you been under a physician’s care for this past depression?
If yes, did the physician prescribe any medication for your depression?
Social support
1. Do you feel you receive adequate emotional support from your partner?
2. Do you feel you receive adequate instrumental support from your partner
(e.g., help with household chores or babysitting)?
3. Do you feel you can rely on your partner when you need help?
4. Do you feel you can confide in your partner?
(repeat same questions for family and again for friends)
Marital satisfaction
1. Are you satisfied with your marriage (or living arrangement)?
2. Are you currently experiencing any marital problems?
3. Are things going well between you and your partner?
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Yes
0
0
0

No
0
0
0

0

0

0

0

0
0

0
0

0

0

0
0

0
0

0

0

0
0

0
0

0

0

0
0
0

0
0
0

TABLE 1

Continued
Life stress
1. Are you currently experiencing any stressful events in your life such as:
financial problems
marital problems
death in the family
serious illness in the family
moving
unemployment
job change

Yes

No

0
0
0
0
0
0
0

0
0
0
0
0
0
0

After delivery, add the following items
Child care stress
1. Is your infant experiencing any health problems?
2. Are you having problems with your baby feeding?
3. Are you having problems with your baby sleeping?

0
0
0

0
0
0

Infant temperament
1. Would you consider your baby irritable or fussy?
2. Does your baby cry a lot?
3. Is your baby difficult to console or soothe?

0
0
0

0
0
0

Maternity blues
1. Did you experience a brief period of tearfulness and
mood swings during the 1st week after delivery?

0

0

COMMENTS:
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
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Figures

Figure 1. Beck’s 4 Stage Process of Postpartum Depression Encompassing Loss of control

A Middle Range Theory of Postpartum Depression
Dr. Cheryl Beck, Teetering on the Edge Theory of Postpartum Depression (2002)
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Figure 2. Adaptation of the Model of Motivational Design (Gatti-Petito et al., 2013).
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Appendices
Appendix A. Research Outcomes
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Appendix B. IRB Approval
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Appendix C
Educational Training Session Evaluation
This form is to be completed by the participant to evaluate the educational session and the
instructor performance.
SESSION TITLE:

Postpartum Depression Screening

SESSION DATE:

PRESENTER: Christy Jeffcoat, MSN, RN

1. Please rate the degree to which the following objectives of this series/lecture were met
(5=Completely; 4=to a high degree; 3=moderately; 2=minimally; 1=not at all)

Upon completion of this program, I will be able to:

Describe the characteristics of postpartum depression.
5

4

3

2

1

Identify risk factors associated with postpartum depression.
5

4

3

2

1

Describe phases of the Teetering on the Edge Theory.
5

4

3

2

1

Identify the importance of postpartum depression screening.
5

4

3

2
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1

Interpret the Postpartum Depression Predictor Inventory-Revised screening tool.
5

4

3

2

1

Describe steps in the administration of the PDPI-R instrument.
5

4

3

2

1

For questions below: 5=Strongly Agree; 4=Agree; 3=Neutral; 2=Disagree; 1=Strongly Disagree

2.

I acquired new skills or knowledge in relation to topic discussed.
5

3.

4

4

2

1

3

2

1

The teaching level was appropriate to audience.
4

3

2

1

The quality of the facilities was adequate for learning.
5

7.

3

4

5
6.

1

The teaching format/length was suitable to content.
5

5.

2

The lecture description was accurate.
5

4.

3

4

3

2

1

Presenter for this session:
Excellent

Good

Fair

Poor

2

1

2

1

Expressed ideas clearly.
4

3

Presented useful examples.
4

3
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Thoroughness of content.
4

3

2

1

2

1

2

1

3

2

1

3

2

1

Speaking/teaching ability.
4

3

Effectiveness of audiovisual aids.
4

3

Responsiveness to questions.
4
Handouts were useful.
4

Comments or suggestions:
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Appendix D
Educational Session: Postpartum Depression Screening Post Test
This document is intended for completion by the participant with 100% accuracy to validate
competency in postpartum depression screening.

1. Symptoms of postpartum depression include all of the following, except:

a.
b.
c.
d.

Irritability
Overwhelming sadness
Edema of the lower extremities
Anger

2. Risk factors associated with development of postpartum depression include all of the
following except:

a.
b.
c.
d.

Marital status
Socioeconomic status
Hypertension
Unplanned/unwanted pregnancy

3. The first step in prevention of postpartum depression is identification of those patients at
risk for developing postpartum depression.

a. True
b. False

4. Teetering on the Edge Theory of Postpartum Depression addresses stages of postpartum
depression:

a. Encountering Terror
b. Dying of Self
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c. Struggling to Survive
d. Regaining Control
e. All of the above

5. Clinicians play an important role in the identification and recognition of risk factors
associated with postpartum depression as a means of prevention.

a. True
b. False

6. The Postpartum Depression Predictor Inventory-Revised (PDPI-R) is a screening tool
that identifies 20 risk factors associated with postpartum depression.

a. True
b. False

7. Administration of the PDPI-R tool should be completed in the:

a.
b.
c.
d.

Hallway
Check-in desk
Exam room
Check-out desk

8. Administration of the PDPI-R tool requires patient consent.

a. True
b. False

9. Administration of the PDPI-R tool should be completed in private by the clinician and the
patient.
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a. True
b. False

10. It is the clinician’s responsibility to report the PDPI-R score to the physician on the same
day of administration of the tool, document the score in the patient chart, flag the patient
chart with blue tape for high-risk score, and place the PDPI-R document in the designated
box at the nurse’s station.

a. True
b. False
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Appendix E
Data Collection Form
Practice Improvement Project

EMR Audit #
Age?
Second trimester (13-27 weeks gestation)

Documentation of administration of the PDPI-R tool by staff?

PDPI-R Score:

Physician notification of PDPI-R score same day?

Follow-up treatment?

Referral to social worker or mental health counselor?

Additional resources?
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